“…However, the biological basis of damp-heat impeding syndrome/hot syndrome of RA is rarely studied by using proteomics technology. Clinical TCM syndrome studies using omics technologies only were the beginning [11]. However, proteomics complements genomics technology and metabolomics technology, and has been successfully used to study CM syndromes, such as syndromes in chronic myocardial ischemia [12], coronary heart disease [13], chronic hepatitis B [14], tuberculosis [15], et al The results of proteomic approaches are useful in clinical research areas, such as diagnosis, disease subtype classification, characterization of metabolic pathways, biomarker quantification, and therapeutic target generation [16].…”